SEC Form D · Amendment · filed August 17, 2020
ELIXIRGEN THERAPEUTICS, INC
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (12)
Naonori Kurokawa · Baltimore, MDDirectorMinoru Ko · Baltimore, MDDirectorAkihiro Ko · Baltimore, MDExec · DirectorMaiko Katadae · Baltimore, MDDirectorRandall J. Combs · St. Louis, MODirectorTimothy L. Elliott · St. Louis, MOExec · DirectorLeah M. Hodges · Garibaldi Highlands, British Columbia, CanadaDirectorMichael R. Farris · St. Louis, MODirectorLijun Lin · Shanghai, IsraelExec · DirectorJeffrey B. Alpert · Leawood, KSDirectorMaximilian Coreth · Alta, UTDirectorChika Watanabe · New York, NYDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗